CMS has suspended prior authorization requirements for some orthoses products under limited circumstances, according to an Aug. 9 update.
The Latest
AxioMed's artificial disc nears FDA approval and five more key updates from spine devicemakers since Aug. 3:
Orthopedic surgeon Michael Suk, MD, is among five additions to Doctivity's board of directors and advisory board.
A 2022 report from Medscape highlights compensation survey results from the last year for U.S. orthopedic surgeons. From average income to incentive bonuses, here are 12 of those survey results.
As consumerism in healthcare continues to rise, so too will competition between practices. Five spine surgeons discuss how practices can stand out in a crowded and increasingly consumer-focused market.
From robotic joint replacements to predicting pain outcomes, artificial intelligence is being used in a variety of ways in orthopedics.
Surgalign's artificial intelligence and augmented reality surgical guidance system, Holo Portal, debuted in the second quarter, and the devicemaker plans to grow its footprint by 2023.
Spine devicemaker Surgalign reported year-over-year revenue decreases in the second quarter and the first half of 2022, according to results posted Aug. 9.
Randal "Randy" Mills, PhD, co-founder of Aziyo Biologics, assumed the role of president and CEO of the company.
NuVasive's executive vice president and chief commercial officer, Massimo Calafiore, is stepping down, the devicemaker said Aug. 9.